Ποια είναι η τιμή για Suzhou Basecare Medical Corporation Limited (2170)

Η τιμή για Suzhou Basecare Medical Corporation Limited (2170) είναι $0.18165525

Ποια είναι η κεφαλαιοποίηση αγοράς για Suzhou Basecare Medical Corporation Limited (2170)

Η κεφαλαιοποίηση αγοράς για Suzhou Basecare Medical Corporation Limited (2170) είναι $49.69M

Suzhou Basecare Medical Corporation Limited (2170) Τιμή και Κεφαλαιοποίηση Αγοράς

Suzhou Basecare Medical Corporation Limited, an investment holding company established in Suzhou, China, in 2010, focuses its business activities within the People's Republic of China. The company primarily engages in the research, development, and manufacturing of genetic testing solutions specifically for assisted reproduction, alongside the distribution of related medical devices and instruments. Its extensive product line includes a range of genetic test kits for reproductive health. These comprise pre-implantation genetic tests such as PGT-A, designed to screen for chromosomal aneuploidies; PGT-M, which identifies single-gene or monogenic defects in pre-implantation embryos; and PGT-SR kits, used to detect chromosomal structural rearrangements often linked to recurrent miscarriages. Additionally, Basecare offers prenatal test kits (CNV kits) and postnatal test kits (WES kits). Complementing its genetic testing offerings, the company supplies various specialized medical equipment, including liquid nitrogen storage dewars, cryostorage systems, automated workstations, sperm quality analyzers, and next-generation sequencing (NGS) sequencers. Beyond manufacturing and sales, Basecare also provides marketing services and develops software for its medical devices and instruments. Its primary clientele consists of hospitals and reproductive clinics.

Η τιμή για 2170	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$19,218.66 $49.69M	NVDA	$5.257T	+10,579,646.64%
$16,812.34 $49.69M	AAPL	$4.599T	+9,254,978.60%
$15,013.37 $49.69M	GOOG	$4.107T	+8,264,658.83%
$13,078.18 $49.69M	MSFT	$3.577T	+7,199,349.09%
$10,263.30 $49.69M	AMZN	$2.807T	+5,649,779.87%

Η τιμή για 2170

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$19,218.66 $49.69M